Phase 1 Study of PF-08046033 in Advanced Solid Tumors
Pfizer
Pfizer
University of Zurich
Peking University Cancer Hospital & Institute
OHSU Knight Cancer Institute
Second Life Therapeutics
Ohio State University Comprehensive Cancer Center
Petrov, Andrey
The University of Hong Kong-Shenzhen Hospital
Convalife (Shanghai) Co., Ltd.